Clinical trial of BNCT for skin malignancies

Clinical trial of BNCT for skin malignancies - Clinical trial of BNCT for skin malignancies

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030555

Enrollment

Registered

2017-12-26

Start date

2017-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

skin malignant tumors

Interventions

nuclear reactor (Kyoto University Research reactor)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Superficial malignancies is suitable for BNCR because of epi-thermal neutron being the less peretrating ability

Exclusion criteria

Exclusion criteria: Boron carrier compornent is not suitable for patients with renal disfunction. Patients with metastasis is not eligible.

Design outcomes

Primary

Measure	Time frame
Local progression free survival rate	—

Secondary

Measure	Time frame
Early/late side effect	—

Countries

Japan

Contacts

Public ContactKawanishi

Kawasaki Medical School Research Support

kenkyu-idai@med.kawasaki-m.ac.jp086-462-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026